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Abstract 
The effect of the thiol containing compounds N-acetylcysteine and captopril on glutathione metabolism in human erythrocytes has been investigated 
non-invasively using ‘H spin echo NMR. N-Acetylcysteine was found to increase the reduced form of glutathione while captopril increased the 
oxidized form, but no changes in the total glutathione concentration were observed. Incubation of the cells with buthionine sulphoximine to inhibit 
de novo glutathione synthesis did not affect the response. The results show that these compounds act by altering the redox balance of glutathione 
rather than by stimulating its synthesis, and that their mechanisms of action are different, and not simply due to the presence of the thiol group. 
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1. Introduction 
Oxidative stress is a facet of many disease processes 
such as chronic heart failure [1,2], rheumatoid arthritis 
[3] and Graves disease [4], and it has recently been impli- 
cated in AIDS [5,6]. Chronic heart failure is further com- 
plicated by reperfusion injury, where the rapid introduc- 
tion of oxygen into the ischaemic region generates active 
oxidants and increases tissue damage [2,7,8]. Manage- 
ment of these diseases includes the administration of 
antioxidant drugs [9] such as captopril [lo] and NAC 
[l l-141, but their mechanism of action at a cellular level 
is not well understood. Like glutathione, these drugs are 
thiol compounds, and some studies have indicated that 
this reactive moiety is responsible for their therapeutic 
action [3,4]. 
Oxidative stress has a profound effect on thiol balance 
and can result in lowered plasma thiol [15], membrane 
thiol [ 161 and erythrocyte lysate thiol [17]. The latter 
measurement is predominantly glutathione (-2 mM). 
Glutathione is a major naturally occurring antioxidant 
and hence the redox balance of endogenous glutathione 
can be used as an index of the stress on the erythrocyte 
[3,4]. Although glutathione responds to oxidative stress 
it needs to be supplemented [ 1 l] or stimulated [18,191 in 
chronic conditions. 
NAC has been reported to stimulate the production of 
reduced glutathione in animal models, and it has been 
*Corresponding author. Fax: (44) (41) 552 5664. 
Abbreviations: BSO, buthionine sulphoximine; NAC, N-acetylcysteine. 
postulated that it is transported into the cytosol and 
deacetylated, thus providing more substrate for the en- 
zyme y-glutamylcysteine synthetase and increasing the 
glutathione concentration in the cells [19,20]. In contrast, 
captopril has been found to cause an increase in intracel- 
lular glutathione oxidation in patients who responded to 
therapy, suggesting that it acts by facilitating direct oxi- 
dant scavenging, rather than by stimulating glutathione 
production [21]. Addition of exogenous reduced glutathi- 
one to human erythrocytes has been reported to stimu- 
late the reduction of intracellular glutathione in a man- 
ner similar to NAC [22,23]. 
Glutathione metabolism can be observed non-inva- 
sively in human erythrocytes using ‘H spin echo NMR, 
as this method can measure both the total concentration 
of glutathione and the ratio of oxidized to reduced gluta- 
thione [3,24]. In the spin echo NMR spectrum of the 
erythrocyte there are 4 resonances assigned to glutathi- 
one (see Fig. 1). The overall concentration of glutathione 
can be determined from the intensity of the glycyl (gi) or 
glutamyl (gJ resonances. The ratio of the &cysteinyl 
resonance (g2) to the glutamyl resonance (gJ gives a 
measure of the glutathione oxidation-reduction status of 
the cell. If the g& ratio is high the glutathione is pre- 
dominantly in the reduced form, whereas if the ratio is 
low the glutathione is mostly present as the disulphide 
[3,24]. ‘H spin echo NMR can therefore be used to differ- 
entiate between alterations in glutathione concentration 
and alterations in redox balance. Although this method 
can be used quantitatively [24], for kinetic studies esti- 
mates of the redox status from the g2/g4 ratio are ade- 
quate. 
In this study ‘H spin echo NMR was used to study the 
mechanism of action of the drugs captopril and N-ace- 
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tylcysteine on the intact human erythrocyte. Glutathione 
signals were monitored to detect changes in glutathione 
concentration or redox equilibrium during treatment. 
y-Glutamylcysteine synthetase was inhibited with 
buthionine sulphoximine to distinguish between mecha- 
nisms of action involving de novo glutathione synthesis 
and changes in glutathione redox balance. 
2. Materials and methods 
2.1. NMR experiments 
All spectra were recorded on a Bruker 250 MHz Aspect 3000 spec- 
trometer, using a Hahn spin echo pulse sequence (90”~r-180”-2) with 
a delay (r) of 60 ms. Samples were maintained at 20°C during the data 
acquisition. Water suppression was achieved using a 0.5 s presaturation 
pulse. The spectral width was 3500 Hz and the acquisition time was 
0.293 s. Each free induction decay contained 2K data points and 2048 
scans were recorded for each spectrum, corresponding to a 32.5 mitt 
acquisition period. Spectra were acquired sequentially over time 
courses of 3 to 10 h. The g2/g4 ratio was determined by measurement 
of peak heights as integration cannot be carried out on negative peaks. 
2.2. Preparation of erythrocytes 
Human blood was obtained from healthy volunteers and was col- 
lected in lithium heparin tubes. The cells were pelleted by centrifugation 
at 600xg and the supernatant and bufly coat were removed. The eryth- 
rocytes were washed twice in PBS (154 mM NaCl, 125 mM NaH,PO,- 
NaOH pH 7.4 in D,O) and once in saline solution (154 mM NaCl pH 
7.4 in D,O). 0.4 ml of erythrocytes were placed in a 5 mm NMR tube 
with 0.2 ml of saline. Cell lysates were prepared by freeze-thawing 
washed erythrocytes in liquid nitrogen in order to prevent dilution of 
the sample. 0.4 ml of lysate plus 0.2 ml of saline were used for analysis. 
2.3. Treatment with thiol-containing compounds 
After the acquisition of a spectrum from an untreated sample, the 
erythrocytes were treated in the NMR tube with thiol compounds at 
the following concentrations: 0.3 mM, 6OpM or 3 PM NAC (a gift from 
Zambon Research), 0.3 mM captopril (a gift from Bristol Myers 
Squibb) or 0.5 mM glutathione. Treatment with each different concen- 
tration or compound was carried out using a fresh cell sample. Similar 
treatments were also carried out with cell lysates in place of cell suspen- 
sions. Untreated samples were observed over the same time course as 
a control experiment. 
2.4. Treatment of erythrocytes with BSO 
After acquisition of a spectrum from untreated cells the erythrocytes 
were incubated with 50 ,uM BSO for 2 h to allow time for the inhibitor 
to interact with y-glutamyl cysteine synthetase. The cells were then 
treated with either 0.3 mM NAC or 0.3 mM captopril. 
2.5. Estimation of NAC uptake by erythrocytes 
Erythrocytes were incubated with 0.3 mM NAC on the bench. Ali- 
quots were taken at 30 min intervals and centrifuged. Sodium acetate 
to a 6nal concentration of 0.5 mM was added to the supernatants and 
these were analysed by spin echo NMR. 
2.6. Cell-free experiments with NAC 
To investigate the possibility of a non-enzymatic reaction between 
NAC and oxidised glutathione 0.3 mM NAC was incubated with 0.3 
mM diglutathione in PBS and the extent of the reaction was monitored 
by NMR. To determine whether glutathione reductase might be able 
to catalyse an interaction between NAC and diglutathione 0.3 mM 
NAC, 0.3 mM diglutathione and glutathione reductase (1.03 units/ ml) 
were incubated in PBS and the reaction was observed by NMR. 
2.7. Calibration of gzlg, ratio 
Spin echo NMR spectra of known ratios of reduced and oxidized 
glutathione in 5 mM sodium phosphate pH 7.4, 100 mM KCl, 5 mM 
MgS04, 10 mg/ml BSA were obtained and the g& ratio was plotted 
against he ratio of reduced to oxidized glutathione. 
3. Results 
Fig. 1 shows a ‘H spin echo NMR spectrum of 0.3 mM 
NAC, and spectra of human erythrocytes before and 
after treatment with 0.3 mM NAC. It can be seen that 
under the conditions used the /I-CH, resonances of gluta- 
thione (g& and NAC are coincident. As the proportion 
of reduced glutathione is calculated from the ratio of the 
g, and g, peaks, it is necessary to determine the contribu- 
tion of NAC to the g, resonance. This was achieved by 
determining the ratio of the acetyl singlet at 2.1 ppm to 
the inverted jl-CH, doublet at 2.8 ppm in a cell-free 
solution (3.5: 1) and using the intensity of the acetyl peak 
in the intact cell spectra to calculate the correction for 
NAC in the g, peak. It was calculated from the gz/& ratio 
calibration curve that the proportion of reduced glutathi- 
one was approximately 75%, which is considerably lower 
than the values that have been obtained from invasive 
methods of analysis. 
The intensity of the NAC acetyl resonance diminished 
during the time course of the NMR experiments, with the 
largest change occurring in the first hour (Fig. 2). As no 
new signals appeared in the spectrum it was concluded 
that this effect was unlikely to be due to metabolism of 
the NAC, especially as the effect also occurred in cell-free 
4:o 3:o 2:o i:o 
PPM 
Fig. 1. ‘H spin echo NMR spectra of erythrocytes and NAC. (a) Intact 
erythrocytes plus 0.3 mM NAC, (b) 0.3 mM NAC and (c) intact control 
erythrocytes. The assignments are as follows: g,, glycinyl CH2; g,, 
/I-cysteinyl CH, of glutathione; g,, glutamyl/I-CH,; &, glutamyl a-CH,; 
n,, b-cysteinyl CH,of NAC; n2, a&y1 of NAC; Cr, creatine. Spectra 
were acquired in 32 min and are the sum of 2048 transients. Chemical 
shifts are given relative to Hz0 at 4.8 ppm. 
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solutions. It is probably caused by signal saturation; the 
delay time of 0.5 s is sufficient to allow complete relaxa- 
tion of the intracellular species, due to the paramagnetic 
effect of iron present in the haemoglobin, but may not 
be long enough for extracellular compounds to relax 
fully. NMR spectra of a solution of NAC acquired using 
the same parameters howed that the signal saturation 
did not affect the ratio of the NAC resonances, and 
therefore that it does not present a problem for the g, 
correction. 
Fig. 2 shows the effect of 0.3 mM NAC on the spectra 
of intact erythrocytes over time. After correction for the 
NAC contribution to the g, resonance it was found that 
treatment with this compound resulted in an increase in 
the g2/g, ratio, corresponding to a shift of the intracellu- 
lar glutathione to a more reduced state. This can be seen 
more clearly in Fig. 3, which also shows that the effect 
was transient, with the g2/g, ratio returning to normal 
after approximately 3 h. The maximum increase in g2/g4 
ratio corresponded to a shift of approximately 20% in the 
~“‘.‘~“‘,“~“‘~“,“““.“,“‘~‘~“‘r 
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Fig. 2. Time course of treatment with NAC. Intact erythrocytes were 
treated with 0.3 mM NAC and ‘H spin echo spectra were acquired after 
(a) 0 min, (b) 32 min, (c) 96 min and (d) 160 min. Spectrum (a) was 
acquired immediately before the addition of NAC. The acquisition 
parameters were as described in Fig. 1. The contribution of the NAC 
B-cysteinyl signal to the g, resonance was calculated from the size of 
the NAC a&y1 resonance. 
0 30 60 90 120 
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Fig. 3. Response of the g2/& ratio to NAC. The g,/g., ratio was calcu- 
lated from the ‘H spin echo spectra of intact erythrocytes treated with 
300 PM, 60 ,uM and 3 PM NAC. The experiments were carried out on 
separate cell samples, hence the variation in the initial g& ratio. The 
gJp, ratio was determined by measurement of peak heights as integra- 
tion cannot be carried out on negative peaks. 
redox balance, from 70-90% reduced glutathione. Treat- 
ment with 2 lower concentrations of NAC (60 ,uM and 
3 PM) resulted in a similar profile, although the length 
of time required to achieve the maximum effect increased 
with decreasing NAC concentration. Analysis of the 
other glutathione resonances in the spectra showed that 
there was no evidence of an increase in the amount of 
total intracellular glutathione, as the intensity of the g, 
and g, resonances did not change with respect to those 
of creatine and carnitine (Fig. 2). 
The effect of treatment of intact erythrocytes with 0.3 
mM captopril and 0.5 mM glutathione is shown in Fig. 
4. Although the spectrum of captopril is complex, at the 
concentrations used most of the resonances are small 
compared to that of the methyl peak at 1.2 ppm and do 
not interfere with the measurement of the g2/g, ratio. 
Captopril resulted in a decrease in the g2/g, ratio, imply- 
ing that the glutathione pool had become more oxidised 
(80%+45% reduced glutathione). Unlike the effect of 
NAC, this did not appear to be a transient effect as there 
were no signs of recovery after 3 h. No changes in the 
intensity of the g, or g, glutathione resonances were ob- 
served, suggesting that the concentration of glutathione 
in the cell was unaffected. Treatment with glutathione 
appeared to decrease the g2/g4 ratio, but the majority of 
the glutathione remains in the extracellular pool, and 
once this had been taken into account there appeared to 
be no effect on the cytosolic glutathione balance. 
In order to investigate the location of NAC during 
treatment of erythrocytes, aliquots of the cell incubation 
were removed at intervals and centrifuged. Each super- 
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Fig. 4. Effect of treatment with captopril and exogenous glutathione. 
NMR spectra of erythrocytes were acquired before (control cells) and 
after 60 min of treatment with either 0.3 mM captopril or 0.3 mM 
glutathione. The graph of g& ratio versus time shows the effect of 
these compounds on the NMR spectra. 
acetate as a reference, and the supernatant was then 
analysed by ‘H NMR (data not shown). There was no 
significant change in the ratio of the NAC acetyl peak 
to the reference peak over a time course comparable to 
those used for the in vivo NMR experiments, and it was 
therefore concluded that there was no significant uptake 
of NAC during treatment. This technique is sufficiently 
sensitive to show that at least 90% of the NAC remained 
in the extracellular space during these experiments. 
The effect of BSO, an inhibitor of y-glutamylcysteine 
synthetase, on the NAC- and captopril-induced changes 
in glutathione balance was determined in similar experi- 
ments. In order to be certain that the enzyme was sub- 
stantially inhibited the cells were incubated with 50 ,uM 
BSO for 2 h; in previous work on erythrocytes 10 PM 
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BSO was found to cause 100% inhibition after 10 min 
[25]. The addition of BSO resulted in a slight decrease in 
the glutathione concentration confirming that it was ef- 
fective in inhibiting y-glutamylcysteine synthetase. How- 
ever, it was found that BSO had little or no effect on the 
alterations in g&, ratio caused by the thiol-containing 
compounds (data not shown). 
NMR spectra from a 1: 1 mixture of NAC and oxidised 
glutathione in the absence of erythrocytes showed that 
no non-enzymatic thiol-transferase reaction occurred 
between these compounds. Experiments were also car- 
ried out to determine whether NAC could act as a sub- 
strate for the enzyme glutathione reductase in a partial 
equilibrium reaction of the type: 
E-SH + GSSG + E-SSG + GSH 
followed by 
E-SSG + NAC-SH + E-SH + NAC-SSG. 
This equilibrium reaction would not involve an overall 
redox change but the result would be to release reduced 
glutathione at the expense of NAC. However, incubation 
of NAC with diglutathione in the presence of glutathione 
reductase did not give any evidence for this interaction; 
the glutathione remained in the oxidised form and the 
formation of NAC-SSG was not observed. In addition 
it was observed that erythrocyte lysates treated with 0.3 
mM NAC did not respond in the same way as intact 
cells, as the g2/g4 ratio remained unchanged uring incu- 
bation. This suggests that the mechanism of action of 
NAC is more complex than has previously been sug- 
gested [181. 
4. Discussion 
NAC and captopril are thiol-containing compounds 
which are used to treat a variety of diseases with an 
oxidative aetiology such as heart failure, rheumatoid ar- 
thritis, Graves disease and AIDS [g-14]. These drugs are 
known to have antioxidant properties but their mecha- 
nism of action at a cellular level is not well understood. 
Glutathione is a major naturally occurring antioxidant, 
and it has been suggested that NAC might affect gluta- 
thione metabolism leading to an increase in its synthesis 
[ 19,201. In this paper the biochemical response of human 
erythrocytes to these compounds has been investigated 
non-invasively using ‘H spin echo NMR to monitor si- 
multaneously the level of glutathione and the ratio of 
oxidised to reduced glutathione. 
The results obtained in this study show that the thiol 
compounds investigated id not act by increasing gluta- 
thione synthesis. The total concentration of glutathione 
in the cell was found to remain unchanged uring treat- 
ment with NAC, but the ratio of reduced to oxidised 
glutathione increased (Fig. 3). Further evidence comes 
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from pretreatment with BSO, which did not alter the 
effect of NAC on the redox balance of glutathione. BSO 
is an inhibitor of y-glutamylcysteine synthetase [25], 
which catalyses the reaction between cysteine and 
y-glutamate, and hence if the action of NAC stems from 
increased synthesis of glutathione via this pathway, 
treatment with BSO should arrest the changes. It can 
therefore be concluded that de novo glutathione synthe- 
sis is not important in this response. It has been sug- 
gested that in some cell types NAC can be deacetylated 
and used as a substrate for glutathione synthesis, leading 
to increased levels of reduced glutathione [19,20]. It is 
possible that the different response obtained with eryth- 
rocytes may result from the lack of a suitable deacetylase 
activity in these cells, or it may reflect the fact that most 
previous studies reporting glutathione synthesis meas- 
ured only the concentration of reduced glutathione, and 
were thus unable to distinguish between a redox shift and 
a change in total concentration. The results obtained in 
this investigation show clearly that NAC does not act as 
a cysteine delivery compound in human erythrocytes, 
but that there is an alternative effect involving changes 
in the glutathione redox balance which have not previ- 
ously been reported in any cell type. 
In vivo, NAC and captopril have a protective role in 
reperfusion injury [10,11,21]. It has been suggested that 
their beneficial action is due to their ability to scavenge 
oxygen radicals [20], thus reducing the stress on the cell 
and resulting in less oxidation of glutathione which is 
also a radical scavenger. However, in this study it was 
found that captopril and NAC produced opposite effects 
on the glutathione pool, with NAC causing a shift to a 
more reduced state and captopril producing a more oxi- 
dised glutathione pool, similar to the effect of penicillam- 
ine [3]. Exogenous glutathione, which has previously 
been reported to stimulate the reduction of intracellular 
glutathione in a manner similar to NAC [22,23], was 
found to have no effect on the endogenous glutathione. 
This pattern of effects on the cytosolic glutathione pool 
contrasts with the abilities of these compounds to 
scavenge the biologically important hydroxyl radical as 
reported in a previous study [26], and therefore it is 
unlikely that these compounds operate through this sim- 
plistic mechanism. Moreover, it appears that NAC and 
captopril act by entirely different mechanisms. 
The results obtained in this study show that the effect 
of NAC is unlikely to be due to a direct and stoichiomet- 
ric interaction with the cytosolic glutathione pool for 
several reasons. Firstly, it was found that the majority 
of the NAC remained in the extracellular fluid under the 
conditions of the experiment. Secondly, much lower con- 
centrations of NAC produced a similar magnitude of 
effect to the higher concentration, with pmolar levels of 
NAC causing significant changes in the redox balance of 
mmolar glutathione. Thirdly, no evidence was obtained 
for the occurrence of either an enzymatic or non-enzy- 
matic reaction between glutathione and NAC in experi- 
ments in vitro. Hence it appears that the effect of NAC 
is multiplicative or stimulatory in nature. 
The difference in the mechanism of action of captopril 
and NAC is also indicated by the different protiles of the 
g& ratio obtained with these compounds. While cap- 
topril caused a stable oxidation of the glutathione pool, 
NAC resulted in a transient effect with the glutathione 
balance recovering by the end of the time course. The 
reason for the transient nature of the NAC response and 
the effect of NAC concentration on the profile of the 
response is not yet clear, but is likely to reflect important 
underlying features of the differential mechanisms of ac- 
tion of these compounds. 
In conclusion, the results of this study show that the 
effects of NAC and captopril on glutathione metabolism 
cannot be due solely to a simple antioxidant property of 
the sulphydryl groups, as the mechanisms of action of 
these two compounds are clearly different. In addition 
NAC treatment results in a shift in the redox balance of 
glutathione to a more reduced state, rather than causing 
synthesis of glutathione [19,20]. The effect of NAC is 
non-stoichiometric and multiplicative in nature. We sug- 
gest that NAC and captopril act either as effecters at 
enzymes of glutathione metabolism such as glutathione 
reductase or glutathione peroxidase, or via an interac- 
tion with the cell membrane leading to a transmembrane 
signalling process. In a previous study evidence for ac- 
tion at the cell membrane of another antioxidant drug, 
penicillamine, has been obtained [3]. An increased under- 
standing of the mechanism of action of these drugs is 
fundamental to the effective treatment of conditions of 
altered oxidant equilibrium such as chronic heart failure 
and AIDS. 
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